Active, not recruitingNCT05046821
Sporadic Inclusion Body Myositis Natural History Study
Studying Inclusion body myositis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, Irvine
- Principal Investigator
- Tahseen Mozaffar, MD FAAN, FANA, MDUniversity of California, Irvine
- Enrollment
- 150 enrolled
- Eligibility
- 40 years · All sexes
- Timeline
- 2021 – 2027
Study locations (13)
- University of California, Los Angeles, Los Angeles, California, United States
- University of California, Irvine, Orange, California, United States
- University of Colorado, Aurora, Colorado, United States
- University of Miami, Miami, Florida, United States
- Kansas University Medical Center, Fairway, Kansas, United States
- Johns Hopkins University, Baltimore, Maryland, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Washington University in St. Louis, St Louis, Missouri, United States
- Ohio State University, Columbus, Ohio, United States
- Oregon Health & Science University, Portland, Oregon, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- Nerve and Muscle Center of Texas, Houston, Texas, United States
- University of Washington, Seattle, Washington, United States
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05046821 on ClinicalTrials.govOther trials for Inclusion body myositis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07072676The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.LMU Klinikum
- RECRUITINGPHASE2NCT06536166Ruxolitinib Treatment in Inclusion Body MyositisAssistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT06450886Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body MyositisAbcuro, Inc.
- RECRUITINGEARLY PHASE1NCT06479863Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body MyositisAustin Neuromuscular Center
- ACTIVE NOT RECRUITINGNCT06153108Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over TimeUniversity of Kansas Medical Center
- ACTIVE NOT RECRUITINGPHASE3NCT04789070Phase III Trial of Sirolimus in IBMUniversity of Kansas Medical Center